FIELD: medicine.
SUBSTANCE: invention relates to compounds of the formula I, where X, Y, L, Z1-Z7, R1-R5, m, n, and p are defined in the claims.
EFFECT: compounds can inhibit protein tyrosine kinases of TRK family, and they can be used for the treatment of hyperproliferative diseases.
29 cl, 2 tbl, 100 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED (2-AZABICYCLO[3.1.0]HEXANE-2-YL)PYRAZOLO[1.5-A]PYRIMIDINE AND IMIDAZO[1.2-B]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS | 2019 |
|
RU2781618C2 |
| SUBSTITUTED PYRROLO [2,3-D] PYRIDAZIN-4-ONES AND PYRAZOLO [3,4-D] PYRIDAZIN-4-ONES AS PROTEINKINASE INHIBITORS | 2017 |
|
RU2749038C2 |
| INHIBITOR OF CERTAIN PROTEIN KINASES | 2016 |
|
RU2732952C2 |
| APOPTOSIS-INDUCING AGENTS | 2018 |
|
RU2782469C2 |
| ANALOGUES OF 4H-PYRAZOLO[1,5-A]BENZIMIDAZOLE COMPOUNDS AS PARP INHIBITORS | 2015 |
|
RU2672722C2 |
| DERIVATIVES OF PYRROLOPYRIMIDINE USEFUL AS JAK-KINASES INHIBITORS | 2012 |
|
RU2618673C2 |
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | 2013 |
|
RU2701156C2 |
| PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
| HEXONE-GLUCOKINASE INHIBITOR AND ITS USE | 2020 |
|
RU2797185C2 |
| AMINOPYRIDINE DERIVATIVES AND APPLICATION THEREOF AS SELECTIVE ALK-2 INHIBITORS | 2017 |
|
RU2777979C2 |
